1. Home
  2. BAND vs PEPG Comparison

BAND vs PEPG Comparison

Compare BAND & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bandwidth Inc.

BAND

Bandwidth Inc.

HOLD

Current Price

$15.18

Market Cap

395.6M

Sector

Technology

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$5.41

Market Cap

425.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAND
PEPG
Founded
2000
2018
Country
United States
United States
Employees
N/A
56
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
395.6M
425.1M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
BAND
PEPG
Price
$15.18
$5.41
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$20.40
$11.67
AVG Volume (30 Days)
511.3K
596.2K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.61
EPS
N/A
N/A
Revenue
$204,113,000.00
N/A
Revenue This Year
$15.34
N/A
Revenue Next Year
$7.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.26
N/A
52 Week Low
$11.33
$0.89
52 Week High
$18.63
$7.80

Technical Indicators

Market Signals
Indicator
BAND
PEPG
Relative Strength Index (RSI) 51.96 44.06
Support Level $15.02 $4.62
Resistance Level $15.21 $5.50
Average True Range (ATR) 0.87 0.59
MACD 0.01 -0.08
Stochastic Oscillator 46.33 21.07

Price Performance

Historical Comparison
BAND
PEPG

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: